IQVIQVIA
$279.21+36% 1Y
$279.21
$156.6652 weeks$279.21
Latest close: a new 52-week highOct 23, 2026what changed →
The financials
IQVIA by the numbers
IQVIA (IQV) reported revenue of $4.37B in Q2 2026 (quarter ended Jun 30, 2026), up 8.7% from the same quarter a year earlier. That came with a gross margin of 33% and net income of $256M (5.9% of revenue). For the full year FY2025, revenue was $16.3B (+5.9% year on year) and net income $1.36B. Its largest segment in Q2 2026 was Research And Development Solutions at $1.14B, 56% of the disclosed total, ahead of Commercial Solutions at 44%. The next results filing is expected around Oct 27, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $4.37B | $4.02B | +8.7% |
| Gross profit | $1.44B | $1.32B | +8.5% |
| Operating income | $506M | $506M | 0.0% |
| Net income | $256M | $266M | −3.8% |
| Diluted EPS | $1.53 | $1.54 | −0.6% |
| Operating | Revenue | Share |
|---|---|---|
| Research And Development Solutions | $1.14B | 56% |
| Commercial Solutions | $895M | 44% |
Business segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $2.04B (+2.8%)
Commercial Solutions grew +8.5% year on yearResearch And Development Solutions +3.1% year on year
Segment Latestquarter on quarteryear on year
- Research And Development Solutions$1.14B$1.14Bquarter on quarter +1.4%year on year +3.1%+1.4%+3.1%
- Commercial Solutions$895.0M$895.0Mquarter on quarter +4.6%year on year +8.5%+4.6%+8.5%
Diagnostics & Research
The closest names by size in the same industry